374 related articles for article (PubMed ID: 22745582)
1. Targeting the mTOR-DEPTOR pathway by CRL E3 ubiquitin ligases: therapeutic application.
Zhao Y; Sun Y
Neoplasia; 2012 May; 14(5):360-7. PubMed ID: 22745582
[TBL] [Abstract][Full Text] [Related]
2. An evolving role for DEPTOR in tumor development and progression.
Wang Z; Zhong J; Inuzuka H; Gao D; Shaik S; Sarkar FH; Wei W
Neoplasia; 2012 May; 14(5):368-75. PubMed ID: 22745583
[TBL] [Abstract][Full Text] [Related]
3. DEPTOR ubiquitination and destruction by SCF(β-TrCP).
Wang Z; Zhong J; Gao D; Inuzuka H; Liu P; Wei W
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E163-9. PubMed ID: 22454292
[TBL] [Abstract][Full Text] [Related]
4. DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy.
Zhao Y; Xiong X; Sun Y
Mol Cell; 2011 Oct; 44(2):304-16. PubMed ID: 22017876
[TBL] [Abstract][Full Text] [Related]
5. mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.
Gao D; Inuzuka H; Tan MK; Fukushima H; Locasale JW; Liu P; Wan L; Zhai B; Chin YR; Shaik S; Lyssiotis CA; Gygi SP; Toker A; Cantley LC; Asara JM; Harper JW; Wei W
Mol Cell; 2011 Oct; 44(2):290-303. PubMed ID: 22017875
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells.
Luo Z; Pan Y; Jeong LS; Liu J; Jia L
Autophagy; 2012 Nov; 8(11):1677-9. PubMed ID: 22874562
[TBL] [Abstract][Full Text] [Related]
7. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
8. Targeting Cullin-RING ligases by MLN4924 induces autophagy via modulating the HIF1-REDD1-TSC1-mTORC1-DEPTOR axis.
Zhao Y; Xiong X; Jia L; Sun Y
Cell Death Dis; 2012 Sep; 3(9):e386. PubMed ID: 22951983
[TBL] [Abstract][Full Text] [Related]
9. SCF E3 ubiquitin ligases as anticancer targets.
Jia L; Sun Y
Curr Cancer Drug Targets; 2011 Mar; 11(3):347-56. PubMed ID: 21247385
[TBL] [Abstract][Full Text] [Related]
10. Ribosomal protein S27-like regulates autophagy via the β-TrCP-DEPTOR-mTORC1 axis.
Xiong X; Liu X; Li H; He H; Sun Y; Zhao Y
Cell Death Dis; 2018 Nov; 9(11):1131. PubMed ID: 30425236
[TBL] [Abstract][Full Text] [Related]
11. Induction of p21-dependent senescence by an NAE inhibitor, MLN4924, as a mechanism of growth suppression.
Jia L; Li H; Sun Y
Neoplasia; 2011 Jun; 13(6):561-9. PubMed ID: 21677879
[TBL] [Abstract][Full Text] [Related]
12. Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery.
Hussain M; Lu Y; Liu YQ; Su K; Zhang J; Liu J; Zhou GB
Pharmacol Res; 2016 Sep; 111():34-42. PubMed ID: 27238229
[TBL] [Abstract][Full Text] [Related]
13. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
[TBL] [Abstract][Full Text] [Related]
14. Protective autophagy induced by RBX1/ROC1 knockdown or CRL inactivation via modulating the DEPTOR-MTOR axis.
Yang D; Zhao Y; Liu J; Sun Y; Jia L
Autophagy; 2012 Dec; 8(12):1856-8. PubMed ID: 22965024
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling.
Scheufele F; Wolf B; Kruse M; Hartmann T; Lempart J; Mühlich S; Pfeiffer AFH; Field LJ; Charron MJ; Pan ZQ; Engelhardt S; Sarikas A
Cell Signal; 2014 Feb; 26(2):233-239. PubMed ID: 24219910
[TBL] [Abstract][Full Text] [Related]
16. A Cullin1-based SCF E3 ubiquitin ligase targets the InR/PI3K/TOR pathway to regulate neuronal pruning.
Wong JJ; Li S; Lim EK; Wang Y; Wang C; Zhang H; Kirilly D; Wu C; Liou YC; Wang H; Yu F
PLoS Biol; 2013 Sep; 11(9):e1001657. PubMed ID: 24068890
[TBL] [Abstract][Full Text] [Related]
17. Cullin-RING Ligases as attractive anti-cancer targets.
Zhao Y; Sun Y
Curr Pharm Des; 2013; 19(18):3215-25. PubMed ID: 23151137
[TBL] [Abstract][Full Text] [Related]
18. The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway.
Tamaddoni A; Mohammadi E; Sedaghat F; Qujeq D; As'Habi A
Pharmacol Res; 2020 Jun; 156():104798. PubMed ID: 32278045
[TBL] [Abstract][Full Text] [Related]
19. SCF
Cai L; Liu L; Li L; Jia L
Cell Signal; 2020 Jan; 65():109440. PubMed ID: 31678254
[TBL] [Abstract][Full Text] [Related]
20. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
Trendelenburg AU; Meyer A; Rohner D; Boyle J; Hatakeyama S; Glass DJ
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1258-70. PubMed ID: 19357233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
